TARA - Protara Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-46.41M

Cash

86.61M

Avg Qtr Burn

-7.096M

Short % of Float

1.32%

Insider Ownership

16.67%

Institutional Own.

51.53%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
IV Choline chloride Details Liver disease, Intestinal failure associated liver disease	Phase 3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TARA-002 Details Lymphatic malformations, Bladder cancer, Non-muscle invasive bladder cancer, Cancer, Solid tumor/s	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TARA-002 Details Bladder cancer, Non-muscle invasive bladder cancer	Phase 1a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.